Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.

Kent DM, Paulus JK, van Klaveren D, D'Agostino R, Goodman S, Hayward R, Ioannidis JPA, Patrick-Lake B, Morton S, Pencina M, Raman G, Ross JS, Selker HP, Varadhan R, Vickers A, Wong JB, Steyerberg EW.

Ann Intern Med. 2019 Nov 12. doi: 10.7326/M18-3667. [Epub ahead of print]

PMID:
31711134
2.

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.

Kent DM, van Klaveren D, Paulus JK, D'Agostino R, Goodman S, Hayward R, Ioannidis JPA, Patrick-Lake B, Morton S, Pencina M, Raman G, Ross JS, Selker HP, Varadhan R, Vickers A, Wong JB, Steyerberg EW.

Ann Intern Med. 2019 Nov 12. doi: 10.7326/M18-3668. [Epub ahead of print]

PMID:
31711094
3.

Clinical Prediction Models for Valvular Heart Disease.

Wessler BS, Lundquist CM, Koethe B, Park JG, Brown K, Williamson T, Ajlan M, Natto Z, Lutz JS, Paulus JK, Kent DM.

J Am Heart Assoc. 2019 Oct 15;8(20):e011972. doi: 10.1161/JAHA.119.011972. Epub 2019 Oct 4.

4.

The use of patient-specific equipoise to support shared decision-making for clinical care and enrollment into clinical trials.

Selker HP, Daudelin DH, Ruthazer R, Kwong M, Lorenzana RC, Hannon DJ, Wong JB, Kent DM, Terrin N, Moreno-Koehler AD, McAlindon TE.

J Clin Transl Sci. 2019 Feb;3(1):27-36. doi: 10.1017/cts.2019.380.

5.

Models with interactions overestimated heterogeneity of treatment effects and were prone to treatment mistargeting.

van Klaveren D, Balan TA, Steyerberg EW, Kent DM.

J Clin Epidemiol. 2019 Oct;114:72-83. doi: 10.1016/j.jclinepi.2019.05.029. Epub 2019 Jun 10.

PMID:
31195109
6.

Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.

Upshaw JN, Ruthazer R, Miller KD, Parsons SK, Erban JK, O'Neill AM, Demissei B, Sledge G, Wagner L, Ky B, Kent DM.

Clin Breast Cancer. 2019 Aug;19(4):259-267.e1. doi: 10.1016/j.clbc.2019.04.012. Epub 2019 May 2.

PMID:
31175052
7.

Untapped potential of multicenter studies: a review of cardiovascular risk prediction models revealed inappropriate analyses and wide variation in reporting.

Wynants L, Kent DM, Timmerman D, Lundquist CM, Van Calster B.

Diagn Progn Res. 2019 Feb 22;3:6. doi: 10.1186/s41512-019-0046-9. eCollection 2019. Review.

8.

Natural Language Processing for the Identification of Silent Brain Infarcts From Neuroimaging Reports.

Fu S, Leung LY, Wang Y, Raulli AO, Kallmes DF, Kinsman KA, Nelson KB, Clark MS, Luetmer PH, Kingsbury PR, Kent DM, Liu H.

JMIR Med Inform. 2019 Apr 21;7(2):e12109. doi: 10.2196/12109.

9.

Patients' responses to incidentally discovered silent brain infarcts - a qualitative study.

Leung LY, Han PKJ, Lundquist C, Weinstein G, Thaler DE, Kent DM.

J Patient Rep Outcomes. 2019 Apr 15;3(1):23. doi: 10.1186/s41687-019-0112-7.

10.

Atrial fibrillation ablation in practice: assessing CABANA generalizability.

Noseworthy PA, Gersh BJ, Kent DM, Piccini JP, Packer DL, Shah ND, Yao X.

Eur Heart J. 2019 Apr 21;40(16):1257-1264. doi: 10.1093/eurheartj/ehz085.

PMID:
30875424
11.

Early withdrawal of life support after resuscitation from cardiac arrest is common and may result in additional deaths.

May TL, Ruthazer R, Riker RR, Friberg H, Patel N, Soreide E, Hand R, Stammet P, Dupont A, Hirsch KG, Agarwal S, Wanscher MJ, Dankiewicz J, Nielsen N, Seder DB, Kent DM.

Resuscitation. 2019 Jun;139:308-313. doi: 10.1016/j.resuscitation.2019.02.031. Epub 2019 Mar 2.

PMID:
30836171
12.

Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency.

Kim DD, Cohen JT, Wong JB, Mohit B, Fendrick AM, Kent DM, Neumann PJ.

Health Aff (Millwood). 2019 Jan;38(1):60-67. doi: 10.1377/hlthaff.2018.05148.

PMID:
30615528
13.

Scoring System to Optimize Pioglitazone Therapy After Stroke Based on Fracture Risk.

Viscoli CM, Kent DM, Conwit R, Dearborn JL, Furie KL, Gorman M, Guarino PD, Inzucchi SE, Stuart A, Young LH, Kernan WN; IRIS Trial Investigators.

Stroke. 2018 Dec 10:STROKEAHA118022745. doi: 10.1161/STROKEAHA.118.022745. [Epub ahead of print]

PMID:
30580725
14.

Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.

Kent DM, Steyerberg E, van Klaveren D.

BMJ. 2018 Dec 10;363:k4245. doi: 10.1136/bmj.k4245. Review.

PMID:
30530757
15.

Risk-Targeted Lung Cancer Screening.

Kumar V, Cohen JT, Neumann PJ, Kent DM.

Ann Intern Med. 2018 Aug 7;169(3):200-201. doi: 10.7326/L18-0237. No abstract available.

PMID:
30083710
16.

Population-Based Validation of a Clinical Prediction Model for Congenital Diaphragmatic Hernias.

Bent DP, Nelson J, Kent DM, Jen HC.

J Pediatr. 2018 Oct;201:160-165.e1. doi: 10.1016/j.jpeds.2018.05.027. Epub 2018 Jun 25.

17.

Big Data and Predictive Analytics: Recalibrating Expectations.

Shah ND, Steyerberg EW, Kent DM.

JAMA. 2018 Jul 3;320(1):27-28. doi: 10.1001/jama.2018.5602. No abstract available.

PMID:
29813156
18.

Evaluation of person-level heterogeneity of treatment effects in published multiperson N-of-1 studies: systematic review and reanalysis.

Raman G, Balk EM, Lai L, Shi J, Chan J, Lutz JS, Dubois RW, Kravitz RL, Kent DM.

BMJ Open. 2018 May 26;8(5):e017641. doi: 10.1136/bmjopen-2017-017641.

19.

Correction: Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study.

Leung LY, Han PKJ, Lundquist C, Weinstein G, Thaler DE, Kent DM.

PLoS One. 2018 May 16;13(5):e0197706. doi: 10.1371/journal.pone.0197706. eCollection 2018.

20.

Effects of Race Are Rarely Included in Clinical Prediction Models for Cardiovascular Disease.

Paulus JK, Wessler BS, Lundquist CM, Kent DM.

J Gen Intern Med. 2018 Sep;33(9):1429-1430. doi: 10.1007/s11606-018-4475-x. No abstract available.

21.

Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.

Gardiner BJ, Nierenberg NE, Chow JK, Ruthazer R, Kent DM, Snydman DR.

Clin Infect Dis. 2018 Oct 15;67(9):1395-1402. doi: 10.1093/cid/ciy295.

PMID:
29635432
22.

Clinicians' perspectives on incidentally discovered silent brain infarcts - A qualitative study.

Leung LY, Han PKJ, Lundquist C, Weinstein G, Thaler DE, Kent DM.

PLoS One. 2018 Mar 29;13(3):e0194971. doi: 10.1371/journal.pone.0194971. eCollection 2018. Erratum in: PLoS One. 2018 May 16;13(5):e0197706.

23.

Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke.

Smith EE, Kent DM, Bulsara KR, Leung LY, Lichtman JH, Reeves MJ, Towfighi A, Whiteley WN, Zahuranec DB; American Heart Association Stroke Council.

Stroke. 2018 Mar;49(3):e111-e122. doi: 10.1161/STR.0000000000000160. Epub 2018 Jan 24. Review. Erratum in: Stroke. 2018 Mar;49(3):e139.

PMID:
29367333
24.

Effect of Dysphagia Screening Strategies on Clinical Outcomes After Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke.

Smith EE, Kent DM, Bulsara KR, Leung LY, Lichtman JH, Reeves MJ, Towfighi A, Whiteley WN, Zahuranec DB; American Heart Association Stroke Council.

Stroke. 2018 Mar;49(3):e123-e128. doi: 10.1161/STR.0000000000000159. Epub 2018 Jan 24. Review. Erratum in: Stroke. 2018 Mar;49(3):e140.

PMID:
29367332
25.

Patient Variability Seldom Assessed in Cost-effectiveness Studies.

Lavelle TA, Kent DM, Lundquist CM, Thorat T, Cohen JT, Wong JB, Olchanski N, Neumann PJ.

Med Decis Making. 2018 May;38(4):487-494. doi: 10.1177/0272989X17746989. Epub 2018 Jan 19. Review.

PMID:
29351053
26.

Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.

Kumar V, Cohen JT, van Klaveren D, Soeteman DI, Wong JB, Neumann PJ, Kent DM.

Ann Intern Med. 2018 Feb 6;168(3):161-169. doi: 10.7326/M17-1401. Epub 2018 Jan 2.

27.

Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model.

Upshaw JN, van Klaveren D, Konstam MA, Kent DM.

Am J Med. 2018 Jun;131(6):676-683.e2. doi: 10.1016/j.amjmed.2017.12.010. Epub 2017 Dec 25.

PMID:
29284111
28.

Tufts PACE Clinical Predictive Model Registry: update 1990 through 2015.

Wessler BS, Paulus J, Lundquist CM, Ajlan M, Natto Z, Janes WA, Jethmalani N, Raman G, Lutz JS, Kent DM.

Diagn Progn Res. 2017 Dec 21;1:20. doi: 10.1186/s41512-017-0021-2. eCollection 2017. Review.

29.

Regional Validation and Recalibration of Clinical Predictive Models for Patients With Acute Heart Failure.

Wessler BS, Ruthazer R, Udelson JE, Gheorghiade M, Zannad F, Maggioni A, Konstam MA, Kent DM.

J Am Heart Assoc. 2017 Nov 18;6(11). pii: e006121. doi: 10.1161/JAHA.117.006121.

30.

Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014.

Shahraz S, Pittas AG, Saadati M, Thomas CP, Lundquist CM, Kent DM.

JAMA. 2017 Nov 14;318(18):1825-1827. doi: 10.1001/jama.2017.11927. No abstract available.

31.

The proposed 'concordance-statistic for benefit' provided a useful metric when modeling heterogeneous treatment effects.

van Klaveren D, Steyerberg EW, Serruys PW, Kent DM.

J Clin Epidemiol. 2018 Feb;94:59-68. doi: 10.1016/j.jclinepi.2017.10.021. Epub 2017 Nov 11.

PMID:
29132832
32.

Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.

Gardiner BJ, Chow JK, Price LL, Nierenberg NE, Kent DM, Snydman DR.

Clin Infect Dis. 2017 Nov 29;65(12):2000-2007. doi: 10.1093/cid/cix696.

33.

Targeting Pioglitazone Hydrochloride Therapy After Stroke or Transient Ischemic Attack According to Pretreatment Risk for Stroke or Myocardial Infarction.

Kernan WN, Viscoli CM, Dearborn JL, Kent DM, Conwit R, Fayad P, Furie KL, Gorman M, Guarino PD, Inzucchi SE, Stuart A, Young LH; Insulin Resistance Intervention After Stroke (IRIS) Trial Investigators.

JAMA Neurol. 2017 Nov 1;74(11):1319-1327. doi: 10.1001/jamaneurol.2017.2136.

34.

Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy.

van Klaveren D, Wong JB, Kent DM, Steyerberg EW.

Med Decis Making. 2017 Oct;37(7):770-778. doi: 10.1177/0272989X17696994. Epub 2017 Mar 20.

35.

Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.

Yao X, Gersh BJ, Sangaralingham LR, Kent DM, Shah ND, Abraham NS, Noseworthy PA.

Am J Cardiol. 2017 Nov 1;120(9):1549-1556. doi: 10.1016/j.amjcard.2017.07.051. Epub 2017 Jul 31.

PMID:
28844514
36.

Race and Ethnicity: A Part of the Equation for Personalized Clinical Decision Making?

Paulus JK, Kent DM.

Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). pii: e003823. doi: 10.1161/CIRCOUTCOMES.117.003823. No abstract available.

37.

Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models.

Olchanski N, Cohen JT, Neumann PJ, Wong JB, Kent DM.

Med Decis Making. 2017 Oct;37(7):790-801. doi: 10.1177/0272989X17704855. Epub 2017 Apr 11.

38.

Response to Comment on Shahraz et al. Do Patient Characteristics Impact Decisions by Clinicians on Hemoglobin A1c Targets? Diabetes Care 2016;38: e145-e146.

Shahraz S, Pittas AG, Lundquist CM, Danaei G, Kent DM.

Diabetes Care. 2016 Dec;39(12):e228. No abstract available.

PMID:
27879366
39.
40.

Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders.

Rosenberg AS, Ruthazer R, Paulus JK, Kent DM, Evens AM, Klein AK.

Clin Lymphoma Myeloma Leuk. 2016 Dec;16(12):684-692.e3. doi: 10.1016/j.clml.2016.09.002. Epub 2016 Sep 17.

41.

Prediabetes Risk in Adult Americans According to a Risk Test.

Shahraz S, Pittas AG, Kent DM.

JAMA Intern Med. 2016 Dec 1;176(12):1861-1863. doi: 10.1001/jamainternmed.2016.5919. No abstract available.

PMID:
27695825
42.

Sex Versus Gender in Recurrent Events Following Acute Coronary Syndrome: A "Femininity Paradox?".

Paulus JK, Kent DM.

J Am Coll Cardiol. 2016 Sep 20;68(12):1371-2. doi: 10.1016/j.jacc.2016.03.612. No abstract available.

43.

Development and Validation of a Predictive Model for Short- and Medium-Term Hospital Readmission Following Heart Valve Surgery.

Pack QR, Priya A, Lagu T, Pekow PS, Engelman R, Kent DM, Lindenauer PK.

J Am Heart Assoc. 2016 Aug 31;5(9). pii: e003544. doi: 10.1161/JAHA.116.003544.

44.

Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction: Model Derivation and External Validation.

Upshaw JN, Konstam MA, Klaveren Dv, Noubary F, Huggins GS, Kent DM.

Circ Heart Fail. 2016 Aug;9(8). pii: e003146. doi: 10.1161/CIRCHEARTFAILURE.116.003146.

45.

Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Messé SR, Gronseth G, Kent DM, Kizer JR, Homma S, Rosterman L, Kasner SE.

Neurology. 2016 Aug 23;87(8):815-21. doi: 10.1212/WNL.0000000000002961. Epub 2016 Jul 27. Review.

46.

Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.

Kent DM, Nelson J, Dahabreh IJ, Rothwell PM, Altman DG, Hayward RA.

Int J Epidemiol. 2016 Dec 1;45(6):2075-2088. doi: 10.1093/ije/dyw118.

47.

Do Patient Characteristics Impact Decisions by Clinicians on Hemoglobin A1c Targets?

Shahraz S, Pittas AG, Lundquist CM, Danaei G, Kent DM.

Diabetes Care. 2016 Sep;39(9):e145-6. doi: 10.2337/dc16-0532. Epub 2016 Jun 22. No abstract available.

48.

Field Synopsis of the Role of Sex in Stroke Prediction Models.

Paulus JK, Lai LY, Lundquist C, Daneshmand A, Buettner H, Lutz JS, Raman G, Wessler BS, Kent DM.

J Am Heart Assoc. 2016 May 5;5(5). pii: e002809. doi: 10.1161/JAHA.115.002809.

49.

Outcomes of Noninvasive and Invasive Ventilation in Patients Hospitalized with Asthma Exacerbation.

Stefan MS, Nathanson BH, Lagu T, Priya A, Pekow PS, Steingrub JS, Hill NS, Goldberg RJ, Kent DM, Lindenauer PK.

Ann Am Thorac Soc. 2016 Jul;13(7):1096-104. doi: 10.1513/AnnalsATS.201510-701OC.

50.

Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials.

Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, Jüni P, Mattle HP, Meier B, Thaler DE.

J Am Coll Cardiol. 2016 Mar 1;67(8):907-17. doi: 10.1016/j.jacc.2015.12.023. Review.

Supplemental Content

Support Center